WCC 2014:射血分数减少的慢性心衰患者临床特征和长期预后

2014-05-07 cath 编译 医学论坛网

中国医学科学院阜外心血管病医院的学者们探讨了中国射血分数减少型慢性心衰(CHF—REF)患者的当前治疗状态,评估了此类患者的长期生存情况,分析其全因死亡和心脏性猝死(SCD)的独立预测因素。结果表明,尽管中国CHF—REF患者(尤其是扩张型心肌病患者)经过了当前的标准治疗,但其预后仍然较差。应辨别CHF—REF患者全因死亡和SCD的预测因素,以更好的评估这些患者的预后。 该研究纳入10所医院的2



中国医学科学院阜外心血管病医院的学者们探讨了中国射血分数减少型慢性心衰(CHF—REF)患者的当前治疗状态,评估了此类患者的长期生存情况,分析其全因死亡和心脏性猝死(SCD)的独立预测因素。结果表明,尽管中国CHF—REF患者(尤其是扩张型心肌病患者)经过了当前的标准治疗,但其预后仍然较差。应辨别CHF—REF患者全因死亡和SCD的预测因素,以更好的评估这些患者的预后。

该研究纳入10所医院的2368例CHF—REF患者,其中2154例患者有完整的随访数据。对两种病原学亚组[扩张型心肌病(DCM)和缺血性心肌病(ICM)]进行了分类。分析患者的临床数据和长期预后情况。

结果显示,在中期随访52个月后,850例(39.46%)患者死亡,这其中302例(35.53%)发生了SCD。与ICM患者相比,DCM患者的全因死亡和SCD未校正发生率较高,但在校正联合变量后两亚组的死亡率相似。

以血管紧张素转换酶抑制剂(ACEI)/血管紧张素受体拮抗剂(ARB)、醛固酮受体拮抗剂、β受体阻滞剂和利尿剂为主导处方药的比率分别为65.97%、74.61%、 68.29%和74.37%。

多变量分析显示,NYHA分级、室性心动过速/室颤(VT/VF)、QRS间期、左心室射血分数(LVEF)和血肌酐为死亡的独立预测因素,而ACEI/ ARB、β受体阻滞剂和他汀类药物与预后较佳具有相关性。VT/VF持续发作对SCD的预测价值最高(HR 4.230,P<0.001)。DCM和 ICM患者死亡的预测因子不同。

文章译自本届世界心脏病学大会(WCC2014)的口头报告摘要,摘要号为0049。

口头报告摘要标题:Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=17751, encodeId=c3a81e75104, content=可以啊,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=127f1616391, createdName=happypig, createdTime=Thu Mar 05 17:00:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842845, encodeId=4b7f18428455f, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Tue Jul 29 04:07:00 CST 2014, time=2014-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645550, encodeId=3e8d16455505a, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97046, encryptionId=79d99e04630, topicName=长期预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e4823226485, createdName=ymljack, createdTime=Mon Oct 06 09:07:00 CST 2014, time=2014-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661847, encodeId=81d6166184e00, content=<a href='/topic/show?id=6db418632f5' target=_blank style='color:#2F92EE;'>#WCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18632, encryptionId=6db418632f5, topicName=WCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ed25348784, createdName=ms3153534357578991, createdTime=Thu Jul 10 07:07:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691595, encodeId=630e1691595b1, content=<a href='/topic/show?id=8ffd4680596' target=_blank style='color:#2F92EE;'>#射血分数减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46805, encryptionId=8ffd4680596, topicName=射血分数减少)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b029265866, createdName=habb, createdTime=Fri May 16 09:07:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10119, encodeId=d26b1011990, content=射血分数减少的慢性心衰5年死亡率相当于癌症, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a03104789, createdName=lidage, createdTime=Sun Jun 29 14:01:00 CST 2014, time=2014-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9755, encodeId=1a449e5531, content=射血分数减少的慢性心衰患者临床特征和长期预后, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=115.238.243.65, createdTime=Mon Jun 09 17:43:00 CST 2014, time=2014-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373266, encodeId=e42a13e3266a3, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri May 09 00:07:00 CST 2014, time=2014-05-09, status=1, ipAttribution=)]
    2015-03-05 happypig

    可以啊,多学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=17751, encodeId=c3a81e75104, content=可以啊,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=127f1616391, createdName=happypig, createdTime=Thu Mar 05 17:00:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842845, encodeId=4b7f18428455f, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Tue Jul 29 04:07:00 CST 2014, time=2014-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645550, encodeId=3e8d16455505a, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97046, encryptionId=79d99e04630, topicName=长期预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e4823226485, createdName=ymljack, createdTime=Mon Oct 06 09:07:00 CST 2014, time=2014-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661847, encodeId=81d6166184e00, content=<a href='/topic/show?id=6db418632f5' target=_blank style='color:#2F92EE;'>#WCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18632, encryptionId=6db418632f5, topicName=WCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ed25348784, createdName=ms3153534357578991, createdTime=Thu Jul 10 07:07:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691595, encodeId=630e1691595b1, content=<a href='/topic/show?id=8ffd4680596' target=_blank style='color:#2F92EE;'>#射血分数减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46805, encryptionId=8ffd4680596, topicName=射血分数减少)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b029265866, createdName=habb, createdTime=Fri May 16 09:07:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10119, encodeId=d26b1011990, content=射血分数减少的慢性心衰5年死亡率相当于癌症, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a03104789, createdName=lidage, createdTime=Sun Jun 29 14:01:00 CST 2014, time=2014-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9755, encodeId=1a449e5531, content=射血分数减少的慢性心衰患者临床特征和长期预后, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=115.238.243.65, createdTime=Mon Jun 09 17:43:00 CST 2014, time=2014-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373266, encodeId=e42a13e3266a3, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri May 09 00:07:00 CST 2014, time=2014-05-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=17751, encodeId=c3a81e75104, content=可以啊,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=127f1616391, createdName=happypig, createdTime=Thu Mar 05 17:00:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842845, encodeId=4b7f18428455f, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Tue Jul 29 04:07:00 CST 2014, time=2014-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645550, encodeId=3e8d16455505a, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97046, encryptionId=79d99e04630, topicName=长期预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e4823226485, createdName=ymljack, createdTime=Mon Oct 06 09:07:00 CST 2014, time=2014-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661847, encodeId=81d6166184e00, content=<a href='/topic/show?id=6db418632f5' target=_blank style='color:#2F92EE;'>#WCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18632, encryptionId=6db418632f5, topicName=WCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ed25348784, createdName=ms3153534357578991, createdTime=Thu Jul 10 07:07:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691595, encodeId=630e1691595b1, content=<a href='/topic/show?id=8ffd4680596' target=_blank style='color:#2F92EE;'>#射血分数减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46805, encryptionId=8ffd4680596, topicName=射血分数减少)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b029265866, createdName=habb, createdTime=Fri May 16 09:07:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10119, encodeId=d26b1011990, content=射血分数减少的慢性心衰5年死亡率相当于癌症, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a03104789, createdName=lidage, createdTime=Sun Jun 29 14:01:00 CST 2014, time=2014-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9755, encodeId=1a449e5531, content=射血分数减少的慢性心衰患者临床特征和长期预后, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=115.238.243.65, createdTime=Mon Jun 09 17:43:00 CST 2014, time=2014-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373266, encodeId=e42a13e3266a3, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri May 09 00:07:00 CST 2014, time=2014-05-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=17751, encodeId=c3a81e75104, content=可以啊,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=127f1616391, createdName=happypig, createdTime=Thu Mar 05 17:00:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842845, encodeId=4b7f18428455f, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Tue Jul 29 04:07:00 CST 2014, time=2014-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645550, encodeId=3e8d16455505a, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97046, encryptionId=79d99e04630, topicName=长期预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e4823226485, createdName=ymljack, createdTime=Mon Oct 06 09:07:00 CST 2014, time=2014-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661847, encodeId=81d6166184e00, content=<a href='/topic/show?id=6db418632f5' target=_blank style='color:#2F92EE;'>#WCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18632, encryptionId=6db418632f5, topicName=WCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ed25348784, createdName=ms3153534357578991, createdTime=Thu Jul 10 07:07:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691595, encodeId=630e1691595b1, content=<a href='/topic/show?id=8ffd4680596' target=_blank style='color:#2F92EE;'>#射血分数减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46805, encryptionId=8ffd4680596, topicName=射血分数减少)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b029265866, createdName=habb, createdTime=Fri May 16 09:07:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10119, encodeId=d26b1011990, content=射血分数减少的慢性心衰5年死亡率相当于癌症, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a03104789, createdName=lidage, createdTime=Sun Jun 29 14:01:00 CST 2014, time=2014-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9755, encodeId=1a449e5531, content=射血分数减少的慢性心衰患者临床特征和长期预后, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=115.238.243.65, createdTime=Mon Jun 09 17:43:00 CST 2014, time=2014-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373266, encodeId=e42a13e3266a3, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri May 09 00:07:00 CST 2014, time=2014-05-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=17751, encodeId=c3a81e75104, content=可以啊,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=127f1616391, createdName=happypig, createdTime=Thu Mar 05 17:00:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842845, encodeId=4b7f18428455f, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Tue Jul 29 04:07:00 CST 2014, time=2014-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645550, encodeId=3e8d16455505a, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97046, encryptionId=79d99e04630, topicName=长期预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e4823226485, createdName=ymljack, createdTime=Mon Oct 06 09:07:00 CST 2014, time=2014-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661847, encodeId=81d6166184e00, content=<a href='/topic/show?id=6db418632f5' target=_blank style='color:#2F92EE;'>#WCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18632, encryptionId=6db418632f5, topicName=WCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ed25348784, createdName=ms3153534357578991, createdTime=Thu Jul 10 07:07:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691595, encodeId=630e1691595b1, content=<a href='/topic/show?id=8ffd4680596' target=_blank style='color:#2F92EE;'>#射血分数减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46805, encryptionId=8ffd4680596, topicName=射血分数减少)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b029265866, createdName=habb, createdTime=Fri May 16 09:07:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10119, encodeId=d26b1011990, content=射血分数减少的慢性心衰5年死亡率相当于癌症, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a03104789, createdName=lidage, createdTime=Sun Jun 29 14:01:00 CST 2014, time=2014-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9755, encodeId=1a449e5531, content=射血分数减少的慢性心衰患者临床特征和长期预后, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=115.238.243.65, createdTime=Mon Jun 09 17:43:00 CST 2014, time=2014-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373266, encodeId=e42a13e3266a3, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri May 09 00:07:00 CST 2014, time=2014-05-09, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=17751, encodeId=c3a81e75104, content=可以啊,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=127f1616391, createdName=happypig, createdTime=Thu Mar 05 17:00:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842845, encodeId=4b7f18428455f, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Tue Jul 29 04:07:00 CST 2014, time=2014-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645550, encodeId=3e8d16455505a, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97046, encryptionId=79d99e04630, topicName=长期预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e4823226485, createdName=ymljack, createdTime=Mon Oct 06 09:07:00 CST 2014, time=2014-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661847, encodeId=81d6166184e00, content=<a href='/topic/show?id=6db418632f5' target=_blank style='color:#2F92EE;'>#WCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18632, encryptionId=6db418632f5, topicName=WCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ed25348784, createdName=ms3153534357578991, createdTime=Thu Jul 10 07:07:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691595, encodeId=630e1691595b1, content=<a href='/topic/show?id=8ffd4680596' target=_blank style='color:#2F92EE;'>#射血分数减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46805, encryptionId=8ffd4680596, topicName=射血分数减少)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b029265866, createdName=habb, createdTime=Fri May 16 09:07:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10119, encodeId=d26b1011990, content=射血分数减少的慢性心衰5年死亡率相当于癌症, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a03104789, createdName=lidage, createdTime=Sun Jun 29 14:01:00 CST 2014, time=2014-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9755, encodeId=1a449e5531, content=射血分数减少的慢性心衰患者临床特征和长期预后, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=115.238.243.65, createdTime=Mon Jun 09 17:43:00 CST 2014, time=2014-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373266, encodeId=e42a13e3266a3, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri May 09 00:07:00 CST 2014, time=2014-05-09, status=1, ipAttribution=)]
    2014-06-29 lidage

    射血分数减少的慢性心衰5年死亡率相当于癌症

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=17751, encodeId=c3a81e75104, content=可以啊,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=127f1616391, createdName=happypig, createdTime=Thu Mar 05 17:00:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842845, encodeId=4b7f18428455f, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Tue Jul 29 04:07:00 CST 2014, time=2014-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645550, encodeId=3e8d16455505a, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97046, encryptionId=79d99e04630, topicName=长期预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e4823226485, createdName=ymljack, createdTime=Mon Oct 06 09:07:00 CST 2014, time=2014-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661847, encodeId=81d6166184e00, content=<a href='/topic/show?id=6db418632f5' target=_blank style='color:#2F92EE;'>#WCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18632, encryptionId=6db418632f5, topicName=WCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ed25348784, createdName=ms3153534357578991, createdTime=Thu Jul 10 07:07:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691595, encodeId=630e1691595b1, content=<a href='/topic/show?id=8ffd4680596' target=_blank style='color:#2F92EE;'>#射血分数减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46805, encryptionId=8ffd4680596, topicName=射血分数减少)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b029265866, createdName=habb, createdTime=Fri May 16 09:07:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10119, encodeId=d26b1011990, content=射血分数减少的慢性心衰5年死亡率相当于癌症, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a03104789, createdName=lidage, createdTime=Sun Jun 29 14:01:00 CST 2014, time=2014-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9755, encodeId=1a449e5531, content=射血分数减少的慢性心衰患者临床特征和长期预后, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=115.238.243.65, createdTime=Mon Jun 09 17:43:00 CST 2014, time=2014-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373266, encodeId=e42a13e3266a3, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri May 09 00:07:00 CST 2014, time=2014-05-09, status=1, ipAttribution=)]
    2014-06-09 115.238.243.65

    射血分数减少的慢性心衰患者临床特征和长期预后

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=17751, encodeId=c3a81e75104, content=可以啊,多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=127f1616391, createdName=happypig, createdTime=Thu Mar 05 17:00:00 CST 2015, time=2015-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842845, encodeId=4b7f18428455f, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Tue Jul 29 04:07:00 CST 2014, time=2014-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645550, encodeId=3e8d16455505a, content=<a href='/topic/show?id=79d99e04630' target=_blank style='color:#2F92EE;'>#长期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97046, encryptionId=79d99e04630, topicName=长期预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e4823226485, createdName=ymljack, createdTime=Mon Oct 06 09:07:00 CST 2014, time=2014-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661847, encodeId=81d6166184e00, content=<a href='/topic/show?id=6db418632f5' target=_blank style='color:#2F92EE;'>#WCC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=18632, encryptionId=6db418632f5, topicName=WCC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99ed25348784, createdName=ms3153534357578991, createdTime=Thu Jul 10 07:07:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691595, encodeId=630e1691595b1, content=<a href='/topic/show?id=8ffd4680596' target=_blank style='color:#2F92EE;'>#射血分数减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46805, encryptionId=8ffd4680596, topicName=射血分数减少)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3b029265866, createdName=habb, createdTime=Fri May 16 09:07:00 CST 2014, time=2014-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10119, encodeId=d26b1011990, content=射血分数减少的慢性心衰5年死亡率相当于癌症, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a03104789, createdName=lidage, createdTime=Sun Jun 29 14:01:00 CST 2014, time=2014-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=9755, encodeId=1a449e5531, content=射血分数减少的慢性心衰患者临床特征和长期预后, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=115.238.243.65, createdTime=Mon Jun 09 17:43:00 CST 2014, time=2014-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373266, encodeId=e42a13e3266a3, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Fri May 09 00:07:00 CST 2014, time=2014-05-09, status=1, ipAttribution=)]

相关资讯

伊伐布雷定或可治疗血管迷走性晕厥

  2012年世界心脏病学大会于4月18~21日在阿联酋迪拜召开,会上报告了摩纳哥学者开展的一项小样本研究。研究人员发现伊伐布雷定对心源性疼痛的治疗有确切作用,并认为伊伐布雷定对其他适合限制最高心率的疾病可能也有用;上述在虚脱之前伴明显心动过速的血管迷走性晕厥(VVS)病人中开展的研究,或许表明了伊伐布雷定有另一个适应证的可能性。   伊伐布雷定是一种抑制窦房结舒张期去极化的药物,据报告它

ACEI降低动脉僵硬度(RCT荟萃分析)

  2012年世界心脏病学大会于4月18~21日在阿联酋迪拜召开,会上公布了英国学者的一项研究显示:血管紧张素转化酶抑制剂(ACEIs)降低不同病理状态病人的动脉僵硬度指标脉搏波速度(PWV)和增强指数(AIx),但是,目前尚不清楚ACEIs对动脉僵硬度的影响是否优于其他降压药物;ACEIs降低动脉僵硬度的能力似乎独立于其降血压的能力。   通过测量主动脉PWV和AIx评估动脉僵硬度已经越来越被

WCC 2014:2014年世界心脏病大会预告

2014年世界心脏病大会(WCC2014)将于2014年5月4日-7日在澳大利亚的墨尔本召开,主办方为世界心脏病联盟。联盟先有200多个会员组织,致力于在全球范围内(尤其是中低收入国家)抗击心脏病和卒中。世界心脏病联盟与其会员组织努力促成全球各国承诺在政策层面来解决心血管健康问题,生成和交流思想,共享最佳规范,推动科学研究,促进知识传播,从而共同征服心血管疾病这一全球头号杀手。世界心脏病联盟的会员

急性心梗PCI后多血管病变的治疗策略

  2012年世界心脏病学大会于近日报告了荷兰学者对多血管病变ST段抬高型心肌梗死(STEMI)的直接经皮冠脉介入(PCI)治疗就诊患者开展的一项研究。研究人员发现:在当前日常临床实践的4种急性心梗和多支血管病变病人的治疗策略中,计划血运重建组【预期2期经皮冠脉介入(PCI)和计划冠脉旁路移植术(CABG)】在长期随访期间的生存率高于1期PCI或药物治疗组;当前数据支持2期PCI是多支血管病变ST

非手术中心无保护左主干病变PCI安全有效

  2012年世界心脏病学大会于4月18~21日在阿联酋迪拜召开,会上公布的英国学者的一项研究表明:在高容量非手术中心,所有年龄组病人的无保护左主干冠脉(ULMCA)经皮冠脉介入(PCI)治疗成功率高,死亡率低;尽管1/4的病人采用了2个支架策略,进行了积极的冠脉血管造影(IVUS)随访,但靶血管血运重建(TVR)仍很低。在上述病人队列中,ULMCA PCI不但安全而且有效。PCI是高龄

巴西长达7年全国性队列研究:PTCA对比CABG

  2012年世界心脏病学大会于4月18~21日在阿联酋迪拜召开,会上公布了巴西学者在冠脉血运重建病人中开展的一项比较经皮冠状动脉腔内成形术(PTCA)和冠状动脉旁路移植术(CABG)对冠状动脉疾病病人的临床益处的全国性队列研究。该研究果显示:年龄和CABG而非性别与预后独立相关。   目前经皮冠状动脉腔内成形术(PTCA)相较于CABG对冠状动脉疾病病人的临床益处。这项研究旨在评估PTCA或C